Healthcare Payer

An entity, organization, government, corporation, health plan sponsor, or any other financial agent who pays a healthcare provider for the healthcare… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Healthcare costs in most developed countries are not clearly linked to better patient and public health outcomes, but… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
OBJECTIVES The Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation Study (NICE Study) (NCT00575172) was a 5-year… (More)
Is this relevant?
2011
2011
We evaluated the cost-effectiveness of universal infant rotavirus (RV) vaccination compared to current standard of care of "no… (More)
Is this relevant?
2009
2009
BACKGROUND AND OBJECTIVE Varenicline is a nicotinic acetylcholine receptor partial agonist that is approved for use as an aid to… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
Is this relevant?
2008
2008
BACKGROUND New products evolving from research and development can only be translated to medical practice on a large scale if… (More)
  • table 1
Is this relevant?
2007
2007
Intensive insulin therapy improves glycosylated haemoglobin (HbA1C) levels and delays the onset of long-term diabetes-related… (More)
  • figure 2
  • figure 1
  • table I
  • figure 3
  • table II
Is this relevant?
2005
2005
Objective: To compare the healthcare costs and effects of budesonide/formoterol in a single inhaler with those of budesonide and… (More)
Is this relevant?
2004
2004
Among patients undergoing elective total hip or knee replacement, prolonged prophylaxis with low-molecular-weight heparin… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2003
2003
OBJECTIVES To assess the cost effectiveness and cost utility of preventing post-exposure influenza infection using the… (More)
Is this relevant?
Review
2002
Review
2002
The success of treatments for chronic obstructive pulmonary disease (COPD) is evaluated by measuring the impact on a range of… (More)
Is this relevant?